UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 04, 2023
Accession Number:0001640455-23-000096
Submission Type:POS AM
CIK:0001640455
Company Name:Jounce Therapeutics, Inc.
File Number:333-223518
Jounce Therapeutics (NASDAQ:JNCE)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Jounce Therapeutics.
Jounce Therapeutics (NASDAQ:JNCE)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Jounce Therapeutics.